Treatment for Food Insecurity

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Mid-Ohio Food Collective, Grove City, OH
Food Insecurity+5 More
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The aim of this research is to undertake a feasibility study to assess uptake and impact of providing access to a widely available weight management and wellness program (WW; formerly known as Weight Watchers) among individuals experiencing food insecurity and overweight/obesity, who are eligible to receive weekly produce at the Mid-Ohio Food Collective (MOFC) through their pre-existing enrollment in the Mid-Ohio Farmacy program. Participants (n=90) adults over the age of 18 with a BMI between 27-50 kg/m2 will be recruited for a 6 month single-arm clinical trial, where participants will be provided with WW Unlimited Workshop + Digital. The primary objective is to test the feasibility and acceptability of a commercial weight loss and wellness program with an established produce prescription program among individuals experiencing food insecurity and overweight/obesity. Secondary outcomes will include assessments related to weight, height, blood pressure, dietary intake, physical activity, food access, depression, wellbeing and economic factors. This feasibility study will help inform future interventions among this population. More specifically, this study will help answer questions about the feasibility and acceptability of such an intervention, adherence to the WW program as described to the participant, and the impact that access to a free weight management and wellness program can have on health-related outcomes among individuals experiencing food insecurity and overweight/obesity.

Eligible Conditions

  • Produce Prescription
  • Weight Change, Body
  • Food Insecurity
  • Overweight and Obesity

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

5 Primary · 10 Secondary · Reporting Duration: Up to 8 months

Up to 8 months
Adherence to study activities (Feasibility and Acceptability)
Attrition rate (Feasibility and Acceptability)
Change in blood pressure (Clinical Outcomes)
Change in body mass index (BMI) (Clinical Outcomes)
Change in body weight (Clinical Outcomes)
Change in depression (SDOH Outcomes)
Change in dietary intake (Clinical Outcomes)
Change in economic trade-offs (SDOH Outcomes)
Change in food security status (SDOH Outcomes)
Change in health related quality of life (SDOH Outcomes)
Change in physical activity (Clinical Outcomes)
Change in well-being (SDOH Outcomes)
Food pantry visits (Feasibility and Acceptability)
Participant Satisfaction with the program (Feasibility and Acceptability)
Total number of patients excluded (Feasibility and Acceptability)

Trial Safety

Safety Progress

1 of 3

Trial Design

0 Treatment Group

90 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: up to 8 months
Closest Location: Mid-Ohio Food Collective · Grove City, OH
N/AFirst Recorded Clinical Trial
1 TrialsResearching Food Insecurity
0 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have reliable internet access.
You have a body mass index (BMI) of 27-50 kg/m2.
You are enrolled in the Mid-Ohio Farmacy (produce prescription program).

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.